ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716260 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716260; 2) Community: the network communities that were significantly associated with the response to NSC 716260; 3) Molecule: the relationships between components within communities and NSC 716260; 4) MDR: the compounds that were significantly associated with the NSC 716260.

NSC Compound Enrichment Correlation
NSC 699767 Null 0.00126952303154153 0.39782536
NSC 707465 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- 0.00126952303154153 0.30809751
NSC 709564 Null 0.00126952303154153 0.29605628
NSC 716334 Null 0.0013187520236934 0.29451791
NSC 725775 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.0013187520236934 0.13478932
NSC 726373 Null 0.0013187520236934 -0.063805321
NSC 735037 Camptothecin Derivative 0.0013187520236934 0.13537682
NSC 748705 Null 0.0013187520236934 0.24483366
NSC 749518 1-[(2Z)-3-amino-3-phenylprop-2-enoyl]-3-phenyl-1H-pyrazol-5-amine 0.0013187520236934 0.14728292
NSC 98572 .beta.-Resorcylaldehyde, 2-pyridylhydrazone 0.0013187520236934 0.22945589
Total:142  Current:10    [First] [Prev] [Next] [Last]